LOC644838 Activators refers to a group of chemical entities that, if the locus were known to be associated with a protein, would be defined by their ability to enhance the activity of said protein encoded by the gene at the LOC644838 genomic locus. The LOC prefix typically denotes a 'locus,' a specific location on a chromosome that may represent a gene whose products and functions are not fully characterized. As of the latest scientific data available to me, there is no recognized gene or protein associated with the designation LOC644838, so the notion of LOC644838 Activators is entirely speculative and does not correspond to a recognized category in chemistry or biology. However, assuming the existence of such a protein, activators would be compounds that bind to it in a manner that increases its natural activity. This could involve a direct interaction with the protein's active site to enhance its function or an allosteric effect where the binding of the activator at a site distinct from the active site induces a conformational change that results in increased activity.
In exploring the concept of LOC644838 Activators further in a theoretical context, the identification and study of such compounds would involve a multifaceted approach. Biochemists would initiate by developing assays to detect the activity of the LOC644838 protein, which would allow for the screening of potential activator compounds. These assays might include colorimetric tests for enzymatic activity, fluorescence-based assays for binding or activity, or electrophysiological measurements if the protein were part of an ion channel or receptor system. Following the initial discovery phase, detailed kinetic studies would be performed to understand the interaction between the activators and the protein, revealing the potency, efficacy, and mechanism of activation. Structural biologists might utilize techniques such as X-ray crystallography or cryo-electron microscopy to elucidate the complex between the protein and activator molecules, providing a detailed view of the interaction at an atomic level. Complementary to these experimental techniques, computational chemists would employ in silico modeling and simulations to predict how these activators interact with the protein and to explore the effects of these interactions on the protein's dynamics and conformation. Through an integrative approach combining empirical evidence with computational predictions, scientists would aim to thoroughly characterize the chemical nature and mode of action of LOC644838 Activators within this theoretical framework.
VEJA TAMBÉM
| Nome do Produto | CAS # | Numero de Catalogo | Quantidade | Preco | Uso e aplicacao | NOTAS |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Este inibidor da DNA metiltransferase poderia levar à desmetilação dos promotores dos genes, aumentando potencialmente a expressão do lincRNA. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Como inibidor da HDAC, a tricostatina A pode alterar a estrutura da cromatina, potencialmente aumentando a transcrição do lincRNA. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
O ácido retinóico pode modular a expressão genética através dos seus receptores nucleares, afectando possivelmente os níveis de lincRNA. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
O lítio influencia a via de sinalização Wnt e pode afetar a expressão de genes, incluindo os lincRNAs. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
Como hormona, o β-Estradiol pode regular a expressão genética através dos receptores de estrogénio, afectando potencialmente a expressão do lincRNA. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Este inibidor da HDAC pode levar à remodelação da cromatina e pode influenciar a expressão do ARN-linc. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Inibidor do fator de transcrição Sp1 que pode alterar a transcrição de genes e lincRNAs regulados por Sp1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
A rapamicina inibe a sinalização mTOR, o que pode resultar em alterações nos padrões de expressão dos genes, incluindo os lincRNAs. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $87.00 $224.00 | ||
Afecta a atividade dos factores de transcrição e a expressão dos genes e pode influenciar de forma não específica a expressão do ARN-linc. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Ao modularem a via PI3K/Akt, estes inibidores podem alterar os perfis de expressão dos genes, incluindo o dos lincRNAs. | ||||||